This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Istituto Europeo Di Oncologia S.r.l.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Elisa Zagarri: Innovator in Cancer Research
Introduction
Elisa Zagarri is a prominent inventor based in Castellanza, Italy. She has made significant contributions to the field of cancer research through her innovative work on thienopyrrole derivatives. Her research focuses on developing compounds that can inhibit histone demethylases, which play a crucial role in various diseases, including cancer.
Latest Patents
Elisa Zagarri holds a patent for "Thienopyrroles as histone demethylase inhibitors." This patent relates to thienopyrrole derivatives, specifically compounds of Formulas (I) and (Ia). These compounds are designed to inhibit KDM1 and can be utilized in the prevention and treatment of cancer, infectious diseases, and conditions characterized by aberrations in cellular energy metabolism, such as obesity. She has 1 patent to her name.
Career Highlights
Elisa Zagarri is affiliated with the Istituto Europeo Di Oncologia S.r.l., where she continues her research and development efforts. Her work is instrumental in advancing therapeutic options for patients suffering from various diseases.
Collaborations
Elisa collaborates with esteemed colleagues, including Paola Vianello and Luca Sartori, who contribute to her research initiatives and help drive innovation in the field.
Conclusion
Elisa Zagarri's contributions to cancer research through her innovative patents highlight her role as a leading inventor in the scientific community. Her work not only advances medical knowledge but also offers hope for effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile